Belgian company Biocartis NV, founded in 2007, aims to provide next-generation diagnostic solutions for improving clinical practice for the benefit of patients, clinicians, payers and industry. Idylla is Biocartis’ fully automated, real-time PCR-based molecular diagnostics system, designed to offer fast and easy access to clinical molecular diagnostic information virtually anywhere and any time. Idylla was commercially launched in September 2014, and its track record so far has convinced key opinion leaders in pathology, oncology and infectious disease across the world of its abilities.
Former Head of Communities, Springer Nature
Sales Account Executive, Springer Nature
CEO & Co-Founder, Zapnito